We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Johns Hopkins Researcher Leads International Effort to Create “Proteinpedia”

A Johns Hopkins researcher has led the effort to compile to date the largest free resource of experimental information about human proteins.
News

Medical Solutions Becomes first UK Commercial Service Provider of Illumina DNA Sequencing and Genotyping Applications

The Board of Medical Solutions plc has announced that it is implementing a new technology platform at its Nottingham laboratory.
News

Online Resource for Peptide Chemists

Activotec has announced the launch of an updated information-rich website.
News

Thermogenesis Announces new Initiative to Address Veterinary Regenerative Medicine

The Company is in the process of completing a research collaboration with UC Davis Collaboration.
News

Vermillion and Johns Hopkins Sign Collaborative Research and License Agreements to Develop Molecular Diagnostic Tests

Vermillion obtains exclusive rights the development of biomarkers that can be applied toward disease detection, classification and monitoring of prevalent cancers.
News

DiscoveRx Corporation Signs Agreement with Cosmo Bio

DiscoveRx Corporation announces the selection of Cosmo Bio as a key distributor for the Japanese territory.
News

Select Biosciences Announces the Availability of Exhibition-only Passes for Screening, ADMET & MedChem Europe

The event will see over 350 people gathering to attend presentations on the latest on biomolecular screening, medicinal chemistry or ADME-toxicology advances.
News

Europe’s most Common Genetic Disease is a Liver Disorder

Researchers discover the origin of hereditary hemochromatosis, a common iron overload disorder, is a genetic defect in the liver.
News

Nara Biosciences Completes Exclusive Licensing Agreement with Boston University

Nara Biosciences has licensed the MyoMouse discovery platform for metabolic and muscle wasting disorder therapies.
News

Amgen and Takeda Announce Exclusive Collaboration in Japan on up to 13 Amgen Clinical Candidates

Under the agreement, Takeda will receive exclusive rights to develop and commercialize select molecules in Japan.
Advertisement